These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia].
    Author: Iutanova NS.
    Journal: Antibiot Khimioter; 2004; 49(3):17-21. PubMed ID: 15344392.
    Abstract:
    The efficacy of clarithromycin retarded release dosage form in the treatment of patients with community-acquired pneumonia was estimated in a open prospective comparative study. The drug was administered in a dose of 500 mg once a day (29 patients) and in a dose of 500 mg twice a day (28 patients). The clinical efficacy in the compared regimens amounted to 90.6 and 93.3% of the patients respectively and the bacteriological efficacy was 93.3 and 84.6% respectively. The adverse reactions were observed in 15.6 and 30.0% of the cases respectively.
    [Abstract] [Full Text] [Related] [New Search]